{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T20:48:09Z","timestamp":1790196489980,"version":"4.1.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,6,22]],"date-time":"2022-06-22T00:00:00Z","timestamp":1655856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,6,22]],"date-time":"2022-06-22T00:00:00Z","timestamp":1655856000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100007496","name":"Biomedical Laboratory Research and Development, VA Office of Research and Development","doi-asserted-by":"publisher","award":["BX0046000"],"award-info":[{"award-number":["BX0046000"]}],"id":[{"id":"10.13039\/100007496","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006379","name":"Office of Research and Development","doi-asserted-by":"publisher","award":["IK2 CX001269"],"award-info":[{"award-number":["IK2 CX001269"]}],"id":[{"id":"10.13039\/100006379","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["R21AR080372"],"award-info":[{"award-number":["R21AR080372"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Patients with rheumatoid arthritis (RA) have increased atherosclerosis; oxidative stress may be a contributor. Oxidative stress produces immunogenic malondialdehyde-acetaldehyde (MAA) protein adducts and anti-MAA antibodies are detectable in human serum. We hypothesized that anti-MAA antibody concentrations are associated with coronary atherosclerosis in RA patients. Serum concentrations of anti-MAA antibodies (IgA, IgG, and IgM) were measured in 166 RA patients using ELISA cross-sectionally. Relationship between anti-MAA antibody concentrations and cardiovascular and metabolic measures and predictive accuracy of anti-MAA antibodies for presence of coronary artery calcium (CAC) and high CAC (\u2265\u2009300 Agatston units or\u2009\u2265\u200975<jats:sup>th<\/jats:sup> percentile) were assessed. Only serum IgA anti-MAA antibody concentration was associated with increased CAC, insulin resistance, and decreased high-density lipoprotein particle number. When added as an interaction term with ACC\/AHA 10-year risk score plus high-sensitivity C-reactive protein, IgA anti-MAA antibody concentration improved the C-statistic for prediction of any CAC and high CAC compared to ACC\/AHA 10-year risk score plus hs-CRP alone. IgA anti-MAA concentration is associated with multiple cardiovascular risk factors and modifies the relationship between ACC\/AHA 10-year risk score and CAC in RA patients. IgA anti-MAA concentration could assist in prediction of atherosclerotic CVD and risk stratification when added to standard measures of cardiovascular risk.<\/jats:p>","DOI":"10.1038\/s41598-022-14954-9","type":"journal-article","created":{"date-parts":[[2022,6,22]],"date-time":"2022-06-22T11:03:22Z","timestamp":1655895802000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Serum anti-malondialdehyde-acetaldehyde IgA antibody concentration improves prediction of coronary atherosclerosis beyond traditional risk factors in patients with rheumatoid arthritis"],"prefix":"10.1038","volume":"12","author":[{"given":"Hannah E.","family":"Lomzenski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffrey M.","family":"Thiele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Duryee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheau-Chiann","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel R.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ted R.","family":"Mikuls","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle J.","family":"Ormseth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,22]]},"reference":[{"issue":"10","key":"14954_CR1","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1002\/acr.20237","volume":"62","author":"YH Rho","year":"2010","unstructured":"Rho, Y. H. et al. Interaction between oxidative stress and high-density lipoprotein cholesterol is associated with severity of coronary artery calcification in rheumatoid arthritis. Arthritis Care Res. (Hoboken). 62(10), 1473\u20131480 (2010).","journal-title":"Arthritis Care Res. (Hoboken)."},{"issue":"4","key":"14954_CR2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0152925","volume":"11","author":"S Mateen","year":"2016","unstructured":"Mateen, S., Moin, S., Khan, A. Q., Zafar, A. & Fatima, N. Increased reactive oxygen species formation and oxidative stress in rheumatoid arthritis. PLoS ONE 11(4), e0152925 (2016).","journal-title":"PLoS ONE"},{"issue":"7","key":"14954_CR3","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1021\/tx000222a","volume":"14","author":"DJ Tuma","year":"2001","unstructured":"Tuma, D. J. et al. Elucidation of reaction scheme describing malondialdehyde-acetaldehyde-protein adduct formation. Chem. Res. Toxicol. 14(7), 822\u2013832 (2001).","journal-title":"Chem. Res. Toxicol."},{"issue":"8","key":"14954_CR4","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1111\/j.1530-0277.1998.tb03973.x","volume":"22","author":"GM Thiele","year":"1998","unstructured":"Thiele, G. M. et al. Soluble proteins modified with acetaldehyde and malondialdehyde are immunogenic in the absence of adjuvant. Alcohol Clin. Exp. Res. 22(8), 1731\u20131739 (1998).","journal-title":"Alcohol Clin. Exp. Res."},{"issue":"1","key":"14954_CR5","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/S0021-9150(98)00153-1","volume":"141","author":"GE Hill","year":"1998","unstructured":"Hill, G. E. et al. Association of malondialdehyde-acetaldehyde (MAA) adducted proteins with atherosclerotic-induced vascular inflammatory injury. Atherosclerosis 141(1), 107\u2013116 (1998).","journal-title":"Atherosclerosis"},{"issue":"10","key":"14954_CR6","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.1093\/rheumatology\/kex212","volume":"56","author":"TR Mikuls","year":"2017","unstructured":"Mikuls, T. R. et al. Enrichment of malondialdehyde-acetaldehyde antibody in the rheumatoid arthritis joint. Rheumatol. (Oxford) 56(10), 1794\u20131803 (2017).","journal-title":"Rheumatol. (Oxford)"},{"issue":"3","key":"14954_CR7","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1002\/art.38969","volume":"67","author":"GM Thiele","year":"2015","unstructured":"Thiele, G. M. et al. Malondialdehyde-acetaldehyde adducts and anti-malondialdehyde-acetaldehyde antibodies in rheumatoid arthritis. Arthritis Rheumatol. 67(3), 645\u2013655 (2015).","journal-title":"Arthritis Rheumatol."},{"issue":"4","key":"14954_CR8","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1053\/he.2000.5373","volume":"31","author":"R Rolla","year":"2000","unstructured":"Rolla, R. et al. Detection of circulating antibodies against malondialdehyde-acetaldehyde adducts in patients with alcohol-induced liver disease. Hepatology 31(4), 878\u2013884 (2000).","journal-title":"Hepatology"},{"issue":"12","key":"14954_CR9","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.1002\/art.41424","volume":"72","author":"TR Mikuls","year":"2020","unstructured":"Mikuls, T. R. et al. Autoantibodies to malondialdehyde-acetaldehyde are detected prior to rheumatoid arthritis diagnosis and after other disease specific autoantibodies. Arthritis Rheumatol. 72(12), 2025\u20132029 (2020).","journal-title":"Arthritis Rheumatol."},{"issue":"10","key":"14954_CR10","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1016\/j.freeradbiomed.2010.08.001","volume":"49","author":"MJ Duryee","year":"2010","unstructured":"Duryee, M. J. et al. Malondialdehyde-acetaldehyde adduct is the dominant epitope after MDA modification of proteins in atherosclerosis. Free Radic. Biol. Med. 49(10), 1480\u20131486 (2010).","journal-title":"Free Radic. Biol. Med."},{"issue":"10","key":"14954_CR11","doi-asserted-by":"publisher","first-page":"3045","DOI":"10.1002\/art.21288","volume":"52","author":"CP Chung","year":"2005","unstructured":"Chung, C. P. et al. Increased coronary-artery atherosclerosis in rheumatoid arthritis: relationship to disease duration and cardiovascular risk factors. Arthritis Rheum. 52(10), 3045\u20133053 (2005).","journal-title":"Arthritis Rheum."},{"issue":"9","key":"14954_CR12","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.3899\/jrheum.200842","volume":"48","author":"E Myasoedova","year":"2021","unstructured":"Myasoedova, E., Davis, J. M., Roger, V. L., Achenbach, S. J. & Crowson, C. S. Improved incidence of cardiovascular disease in patients with incident rheumatoid arthritis in the 2000s: a population-based Cohort Study. J Rheumatol. 48(9), 1379\u20131387 (2021).","journal-title":"J Rheumatol."},{"issue":"5","key":"14954_CR13","doi-asserted-by":"publisher","first-page":"605","DOI":"10.3899\/jrheum.120941","volume":"40","author":"SS McCoy","year":"2013","unstructured":"McCoy, S. S. et al. Longterm outcomes and treatment after myocardial infarction in patients with rheumatoid arthritis. J. Rheumatol. 40(5), 605\u2013610 (2013).","journal-title":"J. Rheumatol."},{"issue":"3","key":"14954_CR14","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.amjcard.2012.03.044","volume":"110","author":"CS Crowson","year":"2012","unstructured":"Crowson, C. S., Matteson, E. L., Roger, V. L., Therneau, T. M. & Gabriel, S. E. Usefulness of risk scores to estimate the risk of cardiovascular disease in patients with rheumatoid arthritis. Am. J. Cardiol. 110(3), 420\u2013424 (2012).","journal-title":"Am. J. Cardiol."},{"issue":"4","key":"14954_CR15","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1136\/annrheumdis-2013-204024","volume":"74","author":"EE Arts","year":"2015","unstructured":"Arts, E. E. et al. Performance of four current risk algorithms in predicting cardiovascular events in patients with early rheumatoid arthritis. Ann. Rheum. Dis. 74(4), 668\u2013674 (2015).","journal-title":"Ann. Rheum. Dis."},{"issue":"2","key":"14954_CR16","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1002\/art.38944","volume":"67","author":"VK Kawai","year":"2015","unstructured":"Kawai, V. K. et al. The ability of the 2013 American College of Cardiology\/American Heart Association cardiovascular risk score to identify rheumatoid arthritis patients with high coronary artery calcification scores. Arthritis Rheumatol. 67(2), 381\u2013385 (2015).","journal-title":"Arthritis Rheumatol."},{"issue":"7","key":"14954_CR17","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1093\/rheumatology\/kex038","volume":"56","author":"CS Crowson","year":"2017","unstructured":"Crowson, C. S. et al. Rheumatoid arthritis-specific cardiovascular risk scores are not superior to general risk scores: a validation analysis of patients from seven countries. Rheumatol. (Oxford) 56(7), 1102\u20131110 (2017).","journal-title":"Rheumatol. (Oxford)"},{"issue":"9","key":"14954_CR18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0107440","volume":"9","author":"DR Anderson","year":"2014","unstructured":"Anderson, D. R. et al. Unique antibody responses to malondialdehyde-acetaldehyde (MAA)-protein adducts predict coronary artery disease. PLoS ONE 9(9), e107440 (2014).","journal-title":"PLoS ONE"},{"issue":"7","key":"14954_CR19","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1007\/BF00280883","volume":"28","author":"DR Matthews","year":"1985","unstructured":"Matthews, D. R. et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28(7), 412\u2013419 (1985).","journal-title":"Diabetologia"},{"issue":"1","key":"14954_CR20","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1002\/art.1780380107","volume":"38","author":"ML Prevoo","year":"1995","unstructured":"Prevoo, M. L. et al. Modified disease activity scores that include twenty-eight-joint counts Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum. 38(1), 44\u201348 (1995).","journal-title":"Arthritis Rheum."},{"issue":"25 Suppl 2","key":"14954_CR21","first-page":"S49","volume":"129","author":"DC Goff Jr","year":"2014","unstructured":"Goff, D. C. Jr. et al. 2013 ACC\/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines. Circulation 129(25 Suppl 2), S49-73 (2014).","journal-title":"Circulation"},{"issue":"25 Pt B","key":"14954_CR22","doi-asserted-by":"publisher","first-page":"2935","DOI":"10.1016\/j.jacc.2013.11.005","volume":"63","author":"DC Goff Jr","year":"2014","unstructured":"Goff, D. C. Jr. et al. 2013 ACC\/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines. J. Am. Coll. Cardiol. 63(25 Pt B), 2935\u20132959 (2014).","journal-title":"J. Am. Coll. Cardiol."},{"issue":"25","key":"14954_CR23","doi-asserted-by":"publisher","first-page":"2631","DOI":"10.1056\/NEJMoa055373","volume":"355","author":"TJ Wang","year":"2006","unstructured":"Wang, T. J. et al. Multiple biomarkers for the prediction of first major cardiovascular events and death. N. Engl. J. Med. 355(25), 2631\u20132639 (2006).","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"14954_CR24","doi-asserted-by":"publisher","first-page":"4084","DOI":"10.1038\/s41467-020-17915-w","volume":"11","author":"H Tao","year":"2020","unstructured":"Tao, H. et al. Scavenging of reactive dicarbonyls with 2-hydroxybenzylamine reduces atherosclerosis in hypercholesterolemic Ldlr(-\/-) mice. Nat. Commun. 11(1), 4084 (2020).","journal-title":"Nat. Commun."},{"issue":"2","key":"14954_CR25","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1056\/NEJM199901143400207","volume":"340","author":"R Ross","year":"1999","unstructured":"Ross, R. Atherosclerosis\u2013an inflammatory disease. N. Engl. J. Med. 340(2), 115\u2013126 (1999).","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"14954_CR26","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1002\/hep.510230431","volume":"23","author":"DJ Tuma","year":"1996","unstructured":"Tuma, D. J., Thiele, G. M., Xu, D., Klassen, L. W. & Sorrell, M. F. Acetaldehyde and malondialdehyde react together to generate distinct protein adducts in the liver during long-term ethanol administration. Hepatology 23(4), 872\u2013880 (1996).","journal-title":"Hepatology"},{"key":"14954_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2020.106433","volume":"83","author":"GM Thiele","year":"2020","unstructured":"Thiele, G. M. et al. Immunogenic and inflammatory responses to citrullinated proteins are enhanced following modification with malondialdehyde-acetaldehyde adducts. Int. Immunopharmacol. 83, 106433 (2020).","journal-title":"Int. Immunopharmacol."},{"key":"14954_CR28","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.intimp.2018.01.022","volume":"56","author":"TR Mikuls","year":"2018","unstructured":"Mikuls, T. R. et al. Malondialdehyde-acetaldehyde antibody concentrations in rheumatoid arthritis and other rheumatic conditions. Int. Immunopharmacol. 56, 113\u2013118 (2018).","journal-title":"Int. Immunopharmacol."},{"issue":"6","key":"14954_CR29","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1111\/j.1530-0277.2011.01443.x","volume":"35","author":"ML McCaskill","year":"2011","unstructured":"McCaskill, M. L. et al. Hybrid malondialdehyde and acetaldehyde protein adducts form in the lungs of mice exposed to alcohol and cigarette smoke. Alcohol Clin. Exp. Res. 35(6), 1106\u20131113 (2011).","journal-title":"Alcohol Clin. Exp. Res."},{"issue":"5","key":"14954_CR30","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1021\/tx0500676","volume":"18","author":"TL Freeman","year":"2005","unstructured":"Freeman, T. L. et al. Aldehydes in cigarette smoke react with the lipid peroxidation product malonaldehyde to form fluorescent protein adducts on lysines. Chem. Res. Toxicol. 18(5), 817\u2013824 (2005).","journal-title":"Chem. Res. Toxicol."},{"key":"14954_CR31","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/978-1-59745-242-7_17","volume":"447","author":"GM Thiele","year":"2008","unstructured":"Thiele, G. M., Klassen, L. W. & Tuma, D. J. Formation and immunological properties of aldehyde-derived protein adducts following alcohol consumption. Methods Mol. Biol. 447, 235\u2013257 (2008).","journal-title":"Methods Mol. Biol."},{"issue":"8","key":"14954_CR32","doi-asserted-by":"publisher","first-page":"501","DOI":"10.3109\/07853890.2013.841322","volume":"45","author":"L Vehkala","year":"2013","unstructured":"Vehkala, L. et al. Plasma IgA antibody levels to malondialdehyde acetaldehyde-adducts are associated with inflammatory mediators, obesity and type 2 diabetes. Ann. Med. 45(8), 501\u2013510 (2013).","journal-title":"Ann. Med."},{"key":"14954_CR33","doi-asserted-by":"publisher","first-page":"233","DOI":"10.3109\/03009748809096769","volume":"75","author":"I Teitsson","year":"1988","unstructured":"Teitsson, I. IgA rheumatoid factor as predictor of disease activity. Scand. J. Rheumatol. Suppl. 75, 233\u2013237 (1988).","journal-title":"Scand. J. Rheumatol. Suppl."},{"issue":"3","key":"14954_CR34","first-page":"301","volume":"14","author":"C Jorgensen","year":"1996","unstructured":"Jorgensen, C., Legouffe, M. C., Bologna, C., Brochier, J. & Sany, J. IgA isotype rheumatoid factor in rheumatoid arthritis: clinical implications. Clin. Exp. Rheumatol. 14(3), 301\u2013304 (1996).","journal-title":"Clin. Exp. Rheumatol."},{"issue":"8","key":"14954_CR35","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1111\/1756-185X.12443","volume":"17","author":"R Sakthiswary","year":"2014","unstructured":"Sakthiswary, R., Shaharir, S. S., Mohd Said, M. S., Asrul, A. W. & Shahril, N. S. IgA rheumatoid factor as a serological predictor of poor response to tumour necrosis factor alpha inhibitors in rheumatoid arthritis. Int. J. Rheum. Dis. 17(8), 872\u2013877 (2014).","journal-title":"Int. J. Rheum. Dis."},{"issue":"1","key":"14954_CR36","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.jaci.2015.10.024","volume":"137","author":"TR Mikuls","year":"2016","unstructured":"Mikuls, T. R., Payne, J. B., Deane, K. D. & Thiele, G. M. Autoimmunity of the lung and oral mucosa in a multisystem inflammatory disease: the spark that lights the fire in rheumatoid arthritis?. J. Allergy Clin. Immunol. 137(1), 28\u201334 (2016).","journal-title":"J. Allergy Clin. Immunol."},{"issue":"1","key":"14954_CR37","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1111\/jre.12486","volume":"53","author":"R Bright","year":"2018","unstructured":"Bright, R. et al. Gingival tissue, an extrasynovial source of malondialdehyde-acetaldehyde adducts, citrullinated and carbamylated proteins. J. Periodontal. Res. 53(1), 139\u2013143 (2018).","journal-title":"J. Periodontal. Res."},{"issue":"9","key":"14954_CR38","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1002\/art.40900","volume":"71","author":"BR England","year":"2019","unstructured":"England, B. R. et al. Malondialdehyde-acetaldehyde adducts and antibody responses in rheumatoid arthritis-associated interstitial lung disease. Arthritis Rheumatol. 71(9), 1483\u20131493 (2019).","journal-title":"Arthritis Rheumatol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-14954-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-14954-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-14954-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T06:23:47Z","timestamp":1669357427000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-14954-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,22]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["14954"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-14954-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,22]]},"assertion":[{"value":"27 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"10547"}}